Fluorescent Peptide-Containing Naphthalimide-Conjugated Boronic Acid-Based Nanoassembly for Rapid Mitochondrial Targeting and Antibacterial Activity
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c01537 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Purnadas Ghosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India. Hauptthemen laut MEDLINE: Naphthalimides, Peptides, Boronic Acids, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, University Grants Commission, Indian Association for the Cultivation of Science.
Abstract (Originalsprache)
Mitochondria have emerged as promising therapeutic targets for the treatment of a wide range of diseases. However, a major challenge in developing effective therapies lies in the poor efficiency of drug delivery, specifically to mitochondria. Most mitochondria-targeting molecules reported so far rely on lipophilic cationic moieties, which often cause cytotoxicity due to their excessive accumulation. To address this limitation, we designed a negatively charged boronic acid-conjugated naphthalimide-appended peptide (PNGB) that spontaneously forms a fluorescent nanoassembly in aqueous medium, emitting greenish-yellow fluorescence. The PNGB nanoassembly exhibits a uniform spherical morphology with an average diameter of 13.5 nm. Remarkably, it enters KB cells (human oral epidermal cancer cells) via a nonendocytic pathway and rapidly localizes within mitochondria, achieving strong colocalization (PCC = 0.90 ± 0.03) within just 5 min of incubation. In addition to its mitochondrial targeting capability, the PNGB nanoassembly displays potent antibacterial activity, with low minimum inhibitory concentrations (MICs) of 24 and 36 μg/mL against Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) bacteria, respectively. These findings highlight the potential of amphiphilic peptide-based nanoassemblies as efficient, rapid mitochondria-targeting agents with dual functionality as antimicrobial therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.
- School of Material Sciences, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India.
ORCID-Profile: Purnadas Ghosh, Rajkumar Sahoo, Arindam Banerjee
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- University Grants Commission
- Indian Association for the Cultivation of Science
Zitieren
APA
Ghosh, P., Sahoo, R., Deb, S., Gayen, K., Bose, S., & Banerjee, A. (2025). Fluorescent Peptide-Containing Naphthalimide-Conjugated Boronic Acid-Based Nanoassembly for Rapid Mitochondrial Targeting and Antibacterial Activity. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01537
Vancouver
Ghosh P, Sahoo R, Deb S, Gayen K, Bose S, Banerjee A. Fluorescent Peptide-Containing Naphthalimide-Conjugated Boronic Acid-Based Nanoassembly for Rapid Mitochondrial Targeting and Antibacterial Activity. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01537
BibTeX
@article{Ghosh2025,
author = {Ghosh, Purnadas and Sahoo, Rajkumar and Deb, Swapnendu and Gayen, Kousik and Bose, Supratim and Banerjee, Arindam},
title = {Fluorescent Peptide-Containing Naphthalimide-Conjugated Boronic Acid-Based Nanoassembly for Rapid Mitochondrial Targeting and Antibacterial Activity},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c01537}
}
EUVIMED